The invention relates to methods for the treatment or prevention of an LXR
mediated disease or condition, including cardiovascular disease and
atherosclerosis, novel compounds of formula (I) for use in such methods
and pharmaceutical compositions comprising compounds for use in such
methods. ##STR00001##